T1	problem 1542 1570	community-acquired pneumonia
T2	problem 1526 1536	bronchitis
T3	problem 329 349	hypercholesterolemia
T4	treatment 792 803	antibiotics
T5	problem 817 827	bronchitis
T6	problem 831 859	community-acquired pneumonia
T7	problem 762 766	copd
T8	problem 490 498	afebrile
T9	problem 1470 1520	chronic obstructive pulmonary disease exacerbation
T10	treatment 217 227	intubation
T11	problem 198 202	copd
T12	problem 373 390	copd exacerbation
T13	treatment 1346 1353	home 02
T14	treatment 1881 1910	oxygen 2 liters nasal cannula
T15	treatment 253 260	home 02
T16	treatment 1179 1198	frequent nebulizers
T17	problem 1203 1207	copd
T18	test 937 955	closer observation
T19	problem 868 898	his tenuous respiratory status
T20	treatment 1843 1853	salmeterol
T21	treatment 608 618	management
T22	problem 622 639	copd exacerbation
T23	problem 659 684	more respiratory distress
T24	test 273 277	fev1
T25	test 307 321	fev1/fvc ratio
T26	problem 1286 1296	desaturate
T27	treatment 1033 1041	chest pt
T28	treatment 1636 1643	flovent
T29	treatment 1093 1111	further management
T30	problem 1115 1136	his copd exacerbation
T31	treatment 1159 1174	p.o. prednisone
T32	problem 408 450	upper respiratory tract infection symptoms
T33	treatment 1750 1767	albuterol inhaler
T34	treatment 578 591	p.o. steroids
T35	treatment 1816 1823	aspirin
T36	treatment 733 757	more frequent nebulizers
T37	treatment 1942 1958	prednisone taper
T38	treatment 714 728	iv solu-medrol
T39	treatment 977 987	intubation
T40	treatment 1664 1676	levofloxacin
T41	problem 1585 1606	myocardial infarction
T42	treatment 1018 1028	nebulizers
R1	TrAP Arg1:T4 Arg2:T5
R2	TrAP Arg1:T4 Arg2:T6
R3	TrAP Arg1:T10 Arg2:T11
R4	PIP Arg1:T11 Arg2:T12
R5	TrAP Arg1:T16 Arg2:T17
R6	TeCP Arg1:T18 Arg2:T19
R7	TrWP Arg1:T21 Arg2:T22
R8	TeCP Arg1:T24 Arg2:T11
R9	TeCP Arg1:T25 Arg2:T11
R10	TrAP Arg1:T29 Arg2:T30
R11	TrAP Arg1:T31 Arg2:T17
R12	TrWP Arg1:T34 Arg2:T22
R13	TrAP Arg1:T36 Arg2:T7
R14	TrAP Arg1:T36 Arg2:T23
R15	TrAP Arg1:T38 Arg2:T7
R16	TrAP Arg1:T38 Arg2:T23
